Blood test for clinical therapy guidance of non-small cell lung cancer patients

Informations projet

LungCARD

N° de convention de subvention: 734790

DOI 10.3030/734790

Projet clôturé

Date de signature de la CE 2 Decembre 2016

Date de début 1 Janvier 2017

Date de fin 31 Octobre 2022

Financé au titre de

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Coût total € 1 039 500,00

Contribution de l’UE € 976 500,00

Coordonné par

STAB VIDA INVESTIGACAO E SERVICOS EM CIENCIAS BIOLOGICAS LDA
Portugal

Livrables

Documents, reports (4)

Final report on outreach activities (including participation in international events, workshops, seminars and publications)

Final report on outreach activities including participation in international events workshops seminars and publications

Mid-term report on outreach activities (including participation in international events, workshops, seminars and publications)
Report on worldwide research and clinical practices related to Lung cancer pharmacogenomics and therapy
Report on proficiency validation

Websites, patent fillings, videos etc. (1)

Project Website

Publications

Peer reviewed articles (3)

Evaluation of clinical and genetic determinants of treatment outcome in EGFR mutation positive advanced lung adenocarcinoma.

Auteurs: Vera Jokic 1, Katarina Savic-Vujovic 2, Jelena Spasic 1, Zoran Bukumiric 3, Mladen Marinkovic 4, Davorin Radosavljevic 1, Milena Cavic 5
Publié dans: SAGE Journals, Numéro 15593258, 2022, ISSN 1559-3258
Éditeur: International Dose-Response Society
DOI: 10.1177/15593258221117354

Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer

Auteurs: Jelena Spasic Milena Cavic Nemanja Stanic Bojan Zaric Tomi Kovacevic Davorin Radosavljevic Ljudmila Nagorni-Obradovic
Publié dans: SAGE Journals, Numéro 15593258, 2022, ISSN 1559-3258
Éditeur: International Dose-Response Society
DOI: 10.1177/15593258221111666

LungCARD - Report on worldwide research and clinical practices related to lung cancer

Auteurs: Radmila Jankovic1 , Helena J. Goncalves2 , Milena Cavic1 , Carla Clemente2 , Michael Lind3 , Alexis Murillo Carrasco4 , Selama Nadifi5 , Meriem Khyatti6 , Tumininu Adebambo7 , Dilshod Egamberdiev8 1 Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; 2 StabVida, Caparica, Portugal; 3 University of HULL, UK; 4 Centro de Genética y Biología Molecular, Facultad de Medicina Humana, Uni
Publié dans: JBUON Open Access Journal aimed at the rapid diffusion of scientific knowledge in Oncology., Numéro Bi-monthly, 2019, ISSN 1107-0625
Éditeur: Zerbinis Medical Publications